NCT03129360 - Levetiracetam in Early Psychosis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 18, 2017

Primary Completion Date

November 3, 2021

Study Completion Date

November 3, 2021

Conditions

PsychosisSchizophreniaSchizo Affective DisorderSchizophreniform

Interventions

DRUG

Levetiracetam

Levetiracetam is an atypical anticonvulsant that is frequently used in children and adults due to its superior tolerability, ease of use and excellent safety profile.

DRUG

Placebo

Prepared in capsules to appear identical to levetiracetam.

Trial Locations (1)

10016

New York University School of Medicine, New York

All Listed Sponsors

collaborator

National Institutes of Health (NIH)

NIH

lead

NYU Langone Health

OTHER